Ibrutinib
Information about Ibrutinib
Ibrutinib Uses
Ibrutinib is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.
Common side effects of Ibrutinib
Headache, Fever, Diarrhea, Stomatitis (Inflammation of the mouth), Nausea, Low blood platelets, Decreased white blood cell count (neutrophils), Fatigue, Musculoskeletal (bone, muscle or joint) pain, Rash, Anemia (low number of red blood cells), Bruising, Muscle spasm, Hemorrhage, Pneumonia, Cough, Dry eye, High blood pressure, Weight loss, Urinary tract infection, Peripheral edema, Subdural hematoma, Second primary malignancies
Available Medicine for Ibrutinib
ImbruvicaJanssen Pharmaceuticals
₹1 to ₹4360002 variant(s)
NitibHetero Healthcare Limited
₹106701 variant(s)
BdbrutBDR Pharmaceuticals Internationals Pvt
₹72001 variant(s)
IbrukemAlkem Laboratories Ltd
₹90001 variant(s)
IB-TibCadila Pharmaceuticals Ltd
₹78991 variant(s)
IbrushilShilpa Medicare Ltd
₹8991 to ₹349192 variant(s)
IbrunatNatco Pharma Ltd
₹95001 variant(s)
TybrivaEmcure Pharmaceuticals Ltd
₹105001 variant(s)
Expert advice for Ibrutinib
- Take it at the same time every day, either with or without food.
- It is advisable to stay hydrated and drink plenty of fluids while taking this medication.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Your doctor may get regular blood tests done to monitor your liver function and blood cell count in your blood.